OUR PARTNERS (Turkish)
Resilience is a new biopharmaceutical company, striving to transform the way that drugs and therapies are manufactured through creating a first-of-its-kind ecosystem for advanced biopharmaceutical manufacturing.
They are leveraging innovation, bringing together leading minds in science and engineering with the most advanced technologies to better serve scientific discovery, and reach those in need, a mission aligned with Jameel Health’s own philosophy. to build a resilient industry future.
In mid-2021, the JIMCO Life Sciences Fund, the dedicated biotech innovation and venture fund of JIMCO, the Jameel Family’s global investment arm, participated in Reslience’s Series C funding round.
